Literature DB >> 22452980

von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion.

Sri R Madabhushi1, Chengwei Shang, Kannayakanahalli M Dayananda, Kate Rittenhouse-Olson, Mary Murphy, Thomas E Ryan, Robert R Montgomery, Sriram Neelamegham.   

Abstract

Noncovalent association between the von Willebrand factor (VWF) propeptide (VWFpp) and mature VWF aids N-terminal multimerization and protein compartmentalization in storage granules. This association is currently thought to dissipate after secretion into blood. In the present study, we examined this proposition by quantifying the affinity and kinetics of VWFpp binding to mature VWF using surface plasmon resonance and by developing novel anti-VWF D'D3 mAbs. Our results show that the only binding site for VWFpp in mature VWF is in its D'D3 domain. At pH 6.2 and 10mM Ca(2+), conditions mimicking intracellular compartments, VWFpp-VWF binding occurs with high affinity (K(D) = 0.2nM, k(off) = 8 × 10(-5) s(-1)). Significant, albeit weaker, binding (K(D) = 25nM, k(off) = 4 × 10(-3) s(-1)) occurs under physiologic conditions of pH 7.4 and 2.5mM Ca(2+). This interaction was also observed in human plasma (K(D) = 50nM). The addition of recombinant VWFpp in both flow-chamber-based platelet adhesion assays and viscometer-based shear-induced platelet aggregation and activation studies reduced platelet adhesion and activation partially. Anti-D'D3 mAb DD3.1, which blocks VWFpp binding to VWF-D'D3, also abrogated platelet adhesion, as shown by shear-induced platelet aggregation and activation studies. Our data demonstrate that VWFpp binding to mature VWF occurs in the circulation, which can regulate the hemostatic potential of VWF by reducing VWF binding to platelet GpIbα.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22452980      PMCID: PMC3367877          DOI: 10.1182/blood-2011-10-387548

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

Review 1.  Functional architecture of Weibel-Palade bodies.

Authors:  Karine M Valentijn; J Evan Sadler; Jack A Valentijn; Jan Voorberg; Jeroen Eikenboom
Journal:  Blood       Date:  2011-01-25       Impact factor: 22.113

2.  Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension.

Authors:  Harish Shankaran; Paschalis Alexandridis; Sriram Neelamegham
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

3.  The ability of poloxamers to inhibit platelet aggregation depends on their physicochemical properties.

Authors:  F Ahmed; P Alexandridis; H Shankaran; S Neelamegham
Journal:  Thromb Haemost       Date:  2001-12       Impact factor: 5.249

4.  The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF.

Authors:  Jonathan B Rosenberg; Sandra L Haberichter; Mary A Jozwiak; Elizabeth A Vokac; Philip A Kroner; Scot A Fahs; Yohko Kawai; Robert R Montgomery
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

5.  Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.

Authors:  Kenji Nishio; Patricia J Anderson; X Long Zheng; J Evan Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

6.  Eccentric localization of von Willebrand factor in an internal structure of platelet alpha-granule resembling that of Weibel-Palade bodies.

Authors:  E M Cramer; D Meyer; R le Menn; J Breton-Gorius
Journal:  Blood       Date:  1985-09       Impact factor: 22.113

7.  Biosynthesis of von Willebrand protein by human megakaryocytes.

Authors:  L A Sporn; S I Chavin; V J Marder; D D Wagner
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

8.  Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage.

Authors:  Sandra L Haberichter; Paula Jacobi; Robert R Montgomery
Journal:  Blood       Date:  2002-10-10       Impact factor: 22.113

9.  An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation.

Authors:  Peter J Lenting; Erik Westein; Virginie Terraube; Anne-Sophie Ribba; Eric G Huizinga; Dominique Meyer; Philip G de Groot; Cécile V Denis
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

10.  Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor.

Authors:  D D Wagner; T Mayadas; V J Marder
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

View more
  16 in total

1.  A systematic analysis of acceptor specificity and reaction kinetics of five human α(2,3)sialyltransferases: Product inhibition studies illustrate reaction mechanism for ST3Gal-I.

Authors:  Rohitesh Gupta; Khushi L Matta; Sriram Neelamegham
Journal:  Biochem Biophys Res Commun       Date:  2015-12-13       Impact factor: 3.575

2.  von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain.

Authors:  Changjie Zhang; Anju Kelkar; Sriram Neelamegham
Journal:  Blood Adv       Date:  2019-04-09

3.  Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation.

Authors:  B A Herbig; S L Diamond
Journal:  J Thromb Haemost       Date:  2015-07-28       Impact factor: 5.824

4.  Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13.

Authors:  Shobhit Gogia; Anju Kelkar; Changjie Zhang; Kannayakanahalli M Dayananda; Sriram Neelamegham
Journal:  Blood Adv       Date:  2017-10-20

5.  The physical spacing between the von Willebrand factor D'D3 and A1 domains regulates platelet adhesion in vitro and in vivo.

Authors:  C Zhang; A Kelkar; M Nasirikenari; J T Y Lau; M Sveinsson; U C Sharma; S Pokharel; S Neelamegham
Journal:  J Thromb Haemost       Date:  2018-01-22       Impact factor: 5.824

Review 6.  Application of microfluidic devices in studies of thrombosis and hemostasis.

Authors:  Changjie Zhang; Sriram Neelamegham
Journal:  Platelets       Date:  2017-06-05       Impact factor: 3.862

Review 7.  Segmental outflow of aqueous humor in mouse and human.

Authors:  Teresia A Carreon; Genea Edwards; Haiyan Wang; Sanjoy K Bhattacharya
Journal:  Exp Eye Res       Date:  2016-08-03       Impact factor: 3.467

8.  von Willebrand factor propeptide: biology and clinical utility.

Authors:  Sandra L Haberichter
Journal:  Blood       Date:  2015-07-27       Impact factor: 22.113

9.  Compromised shear-dependent cleavage of type 2N von Willebrand factor variants by ADAMTS13 in the presence of factor VIII.

Authors:  Christopher G Skipwith; Sandra L Haberichter; Ashley Gehrand; X Long Zheng
Journal:  Thromb Haemost       Date:  2013-05-02       Impact factor: 5.249

10.  FVIII half-life extension by coadministration of a D'D3 albumin fusion protein in mice, rabbits, rats, and monkeys.

Authors:  Sabine Pestel; Hans-Wilhelm Beltz; Philipp Claar; Holger Lind; Marcel Mischnik; Elmar Raquet; Arna Andrews; Jason Simmonds; Vesna Tomasetig; Steven K Dower; Anna Tjärnlund-Wolf; Stefan Schulte; Peter M Schmidt; Thomas Weimer
Journal:  Blood Adv       Date:  2020-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.